LEADER 01948oam  2200433Ia 450 
001 9910698737203321
005 20091223162307.0
035   $a(CKB)5470000002396485
035   $a(OCoLC)318814007
035   $a(EXLCZ)995470000002396485
100   $a20090420d2008      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aQ4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions$b[electronic resource] $eannex 5, disintegration test general chapter
210  1$a[Silver Spring, MD] :$c[Center for Drug Evaluation and Research] ;$a[Rockville, MD]:$c[U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research],$d[2008]
215   $a5 unnumbered pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on Apr. 20, 2009).
300   $a"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use"--p. [2].
300   $a"Draft consensus guideline."
300   $a"Current step 2 version, dated June 5, 2008."
320   $aIncludes bibliographical references (page [4]).
517   $aQ4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions 
606   $aTablets (Medicine)$xTesting
606   $aCapsules (Pharmacy)$xTesting
615  0$aTablets (Medicine)$xTesting.
615  0$aCapsules (Pharmacy)$xTesting.
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 12$aInternational Conference on Harmonisation.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910698737203321
996   $aQ4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions$93471792
997   $aUNINA